189 related articles for article (PubMed ID: 14978536)
1. 99mTc sestamibi scintimammography. Screening mammographic non-palpable suspicious breast lesions: preliminary results.
Bekiş R; Derebek E; Balci P; Koçdor MA; Değirmenci B; Canda T; Durak H
Nuklearmedizin; 2004 Feb; 43(1):16-20. PubMed ID: 14978536
[TBL] [Abstract][Full Text] [Related]
2. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.
Gommans GM; van der Zant FM; van Dongen A; Boer RO; Teule GJ; de Waard JW
Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524
[TBL] [Abstract][Full Text] [Related]
3. Tc-99m-tetrofosmin scintimammography: a prospective study in primary breast lesions.
Lind P; Gallowitsch HJ; Kogler D; Kresnik E; Mikosch P; Gomez I
Nuklearmedizin; 1996 Dec; 35(6):225-9. PubMed ID: 8976502
[TBL] [Abstract][Full Text] [Related]
4. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH
Anticancer Res; 2000; 20(3B):2133-6. PubMed ID: 10928166
[TBL] [Abstract][Full Text] [Related]
5. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions.
Mekhmandarov S; Sandbank J; Cohen M; Lelcuk S; Lubin E
J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742
[TBL] [Abstract][Full Text] [Related]
6. Positive predictive value of 99mTc sestamibi scintimammography in patients with non-palpable, mammographically detected, suspicious, breast lesions.
Lumachi F; Zucchetta P; Marzola MC; Ferretti G; Povolato M; Paris MK; Brandes AA; Bui F
Nucl Med Commun; 2002 Nov; 23(11):1073-8. PubMed ID: 12411835
[TBL] [Abstract][Full Text] [Related]
7. 99Tcm-MIBI scintimammography in the evaluation of breast lesions and axillary involvement: a comparison with mammography and histopathological diagnosis.
Arslan N; Oztürk E; Ilgan S; Urhan M; Karaçalioglu O; Pekcan M; Tufan T; Bayhan H
Nucl Med Commun; 1999 Apr; 20(4):317-25. PubMed ID: 10319351
[TBL] [Abstract][Full Text] [Related]
8. The role of technetium-99m methoxyisobutylisonitrile scintimammography in diagnosis of breast cancer in patients with mammographically dense breasts.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Kao CH
Anticancer Res; 2000; 20(5C):3755-8. PubMed ID: 11268450
[TBL] [Abstract][Full Text] [Related]
9. Tc-99m tetrofosmin scintigraphy as an adjunct to plain-film mammography in palpable breast lesions.
Fenlon HM; Phelan N; Tierney S; Gorey T; Ennis JT
Clin Radiol; 1998 Jan; 53(1):17-24. PubMed ID: 9464430
[TBL] [Abstract][Full Text] [Related]
10. Scintimammography with Tc-99m sestamibi.
Khalkhali I; Iraniha S; Cutrone JA; Diggles LE; Klein SR
Acta Med Austriaca; 1997; 24(2):46-9. PubMed ID: 9227786
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of mammographic breast lesions with Tc-99m sestamibi scintimammography and contrast enhanced MRI.
Sommer H; Tiling R; Pechmann M; Kindermann G; Kress K; Moser R; Tatsch K; Hahn K; Pfluger T; Assemi C
Zentralbl Gynakol; 1997; 119(1):6-11. PubMed ID: 9050197
[TBL] [Abstract][Full Text] [Related]
12. The role of 99m Tc-sestamibi scintimammography and colour Doppler ultrasonography in the evaluation of breast lesions.
Koukouraki S; Koukourakis MI; Vagios E; Velidaki A; Tsiftsis D; Karkavitsas N
Nucl Med Commun; 2001 Nov; 22(11):1243-8. PubMed ID: 11606891
[TBL] [Abstract][Full Text] [Related]
13. Is (99m)Tc-sestamibi scintimammography complementary to conventional mammography for detecting breast cancer in patients with palpable masses?
Alonso O; Massardo T; Delgado LB; Horvath J; Kabasakal L; Llamas-Olier A; Maunda KK; Morales R; Padhy AK; Shankar UR
J Nucl Med; 2001 Nov; 42(11):1614-21. PubMed ID: 11696629
[TBL] [Abstract][Full Text] [Related]
14. Contribution of 99mTc-anti-carcinoembryonic antigen antibody and 99mTc-sestamibi scintimammography in the evaluation of high risk palpable breast lesions.
Sanidas EE; Koukouraki S; Velidaki A; Manios A; Stathopoulos E; De Bree E; Kafousi M; Kodogiannis E; Karkavitsas N; Tsiftsis DD
Nucl Med Commun; 2003 Mar; 24(3):291-6. PubMed ID: 12612470
[TBL] [Abstract][Full Text] [Related]
15. Optimization of X-ray mammography and technetium-99m methoxyisobutylisonitrile scintimammography in the diagnosis of non-palpable breast lesions.
Uriarte I; Carril JM; Quirce R; Gutiérrez-Mendiguchía C; Blanco I; Banzo I; Vega A; Hernández A
Eur J Nucl Med; 1998 May; 25(5):491-6. PubMed ID: 9575244
[TBL] [Abstract][Full Text] [Related]
16. Scintimammography using Tc-99m tetrofosmin.
Lind P; Umschaden HW; Forsthuber E; Oman J; Kerschbaumer K; Gallowitsch HJ; Mikosch P; Kresnik E; Molnar M; Gomez I
Acta Med Austriaca; 1997; 24(2):50-4. PubMed ID: 9227787
[TBL] [Abstract][Full Text] [Related]
17. Comparison between 99mTc-sestamibi scintimammography and X-ray mammography in the characterization of clusters of microcalcifications: a prospective long-term study.
Grosso M; Chiacchio S; Bianchi F; Traino C; Marini C; Cilotti A; Manca G; Volterrani D; Roncella M; Rampin L; Marzola MC; Rubello D; Mariani G
Anticancer Res; 2009 Oct; 29(10):4251-7. PubMed ID: 19846982
[TBL] [Abstract][Full Text] [Related]
18. Scintimammography with technetium-99m methoxyisobutylisonitrile: results of a prospective European multicentre trial.
Palmedo H; Biersack HJ; Lastoria S; Maublant J; Prats E; Stegner HE; Bourgeois P; Hustinx R; Hilson AJ; Bischof-Delaloye A
Eur J Nucl Med; 1998 Apr; 25(4):375-85. PubMed ID: 9553167
[TBL] [Abstract][Full Text] [Related]
19. Scintimammography with Tc-99m MIBI in patients with suspicion of primary breast cancer.
Palmedo H; Schomburg A; Grünwald F; Mallmann P; Boldt I; Biersack HJ
Nucl Med Biol; 1996 Aug; 23(6):681-4. PubMed ID: 8940710
[TBL] [Abstract][Full Text] [Related]
20. Clinical experience with 99mTc-MIBI scintimammography in patients with breast microcalcifications.
Fondrinier E; Muratet JP; Anglade E; Fauvet R; Berger V; Lorimier G; Jallet P
Breast; 2004 Aug; 13(4):316-20. PubMed ID: 15325666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
